Metal Metabolism, Inborn Errors - 6 Studies Found

Recruiting : Study of ALXN1101 in Neonates With Molybdenum Cofactor Deficiency (MOCD) Type A
: Molybdenum Cofactor Deficiency, Type A
: 2015-12-03
: Drug: ALXN1101
Active, not recruiting : Safety & Efficacy Study of ALXN1101 in Pediatric Patients With MoCD Type A Currently Treated With rcPMP
: Molybdenum Cofactor Deficiency, Type A
: 2014-01-09
: Drug: ALXN1101 IV infusion
Completed : Phase 1 Single Dose Study of ALXN1101 in Healthy Volunteers
:
  • Molybdenum Cofactor Deficiency (MoCD)
  • Rare Autosomal Recessive Disorder
  • Drug: ALXN1101 Randomized to r
Recruiting : Apotransferrin in Atransferrinemia
: Congenital Atransferrinemia
: 2013-02-20
: Drug: Human apotransferrin intravenous infusion
Completed : A Retrospective, Observational, Noninterventional Data Collection Study for Patients With Molybdenum Cofactor Deficiency Who Have Been Previously Treated With Cyclic Pyranopterin Monophosphate (cPMP)
: Molybdenum Cofactor Deficiency
: 2012-07-12
Withdrawn : Study of cPMP (Precusor Z) to Treat Molybdenum Cofactor Deficiency (MoCD) Type A
: Molybdenum Cofactor Deficiency Type A
: 2009-07-10
: Drug: cPMP Intravenous solution administered daily. Dose titrated from 80 μg/kg on Days 1-12 to 120